跳至主要内容
临床试验/CTRI/2020/08/027497
CTRI/2020/08/027497尚未招募4 期

A Prospective, open labelled, randomized interventional study to assess the effectiveness of Letrozole- an aromatase inhibitor in the medical management of Endometriosis. - LIME STUDY

Internal Fluid Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Women in reproductive age group of 18 to 45years not planning on conceiving for next 6months and diagnosed with endometriosis.
  • 2.Women who are planned for medical management and not for surgical
  • management.
  • 3.Women with pain score of more than or equal to seven in Numerical rating scale.

排除标准

  • 1.Post menopausal women.
  • 2.Women planning on conceiving in the next 6months.
  • 3.Women who took therapies other than NSAIDs for 3months prior to inclusion in the study.
  • 4.Previous use of aromatase inhibitors.
  • 5.Women with osteoporosis or osteopenia.
  • 6.Women with past or present history of seizure disorders, pulmonary, cardiac, hepatic or renal diseases.

研究者

发起方
Internal Fluid Research

相似试验